EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neuroprotective Role of E3 Ubiquitin Ligase TRIM2 in Parkinson's Disease: Attenuation of Oxidative Stress and Apoptosis via Promoting ELAVL1 Ubiquitination

Wei Liang iD, WenJie Sun, ZhiJun Zhao, Ke Song, JinYing Jia

CNS Neuroscience & Therapeutics · 2026-08 · 32 (8)

DOI: 10.1002/cns.71075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 12.08.2026. Verfasst von Wei Liang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Oxidative Stress, Ubiquitin-Protein Ligases, Ubiquitination, Apoptosis. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Science and Technology Research Program Jointly Established Project of Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Parkinson's disease (PD) is characterized by the progressive loss of dopaminergic neurons, where oxidative stress and neuronal apoptosis are key pathogenic events. In this study, we identified a downregulated TRIM2 in the substantia nigra pars compacta (SNc) of PD rats based on label‐free proteomics. However, the impact of TRIM2 on PD is unknown.

Methods

We used 6‐hydroxydopamine (6‐OHDA) to construct a PD model in vivo and in vitro.

Results

TRIM2 overexpression alleviated neurobehavioral deficits, mitigated the loss of dopaminergic neurons, and suppressed oxidative stress and apoptosis in the SNc of PD rats. These effects were also observed in the 6‐OHDA‐treated differentiated BE (2)‐M17 cells. Mechanistically, the RNA‐binding protein ELAVL1 was identified as a critical downstream target, given that the database predicts it to be a TRIM2‐interacted protein and a PD‐related protein. Herein, TRIM2 directly interacted with ELAVL1 and promoted its ubiquitin‐mediated degradation. Crucially, rescue experiments confirmed that the neuroprotection conferred by TRIM2 was counteracted by ELAVL1 overexpression in the 6‐OHDA‐treated BE (2)‐M17 cells that exhibited neuronal‐like properties.

Conclusion

Our findings uncovered a novel TRIM2‐ELAVL1 axis as a pivotal regulatory mechanism in PD pathogenesis, positioning TRIM2 as a potential target for therapeutic intervention in PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oxidative StressUbiquitin-Protein LigasesUbiquitinationApoptosisELAV-Like Protein 1Tripartite Motif ProteinsParkinson DiseaseAnimalsRatsOxidopamineMaleHumansRats, Sprague-Dawley

Stichwörter der Autor:innen

ELAVL1TRIM2parkinson's diseaseubiquitination

Substanzen

Ubiquitin-Protein LigasesOxidopamineELAV-Like Protein 1Tripartite Motif Proteins

Autor:innen und Institutionen

  • Department of Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Traditional Chinese Medicine Integrated Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

ORCID-Profile: Wei Liang

Förderung

  • Medical Science and Technology Research Program Jointly Established Project of Henan Province

Zitieren

APA

Liang, W., Sun, W., Zhao, Z., Song, K., & Jia, J. (2026). Neuroprotective Role of E3 Ubiquitin Ligase TRIM2 in Parkinson's Disease: Attenuation of Oxidative Stress and Apoptosis via Promoting ELAVL1 Ubiquitination. CNS Neuroscience & Therapeutics, 32(8). https://doi.org/10.1002/cns.71075

Vancouver

Liang W, Sun W, Zhao Z, Song K, Jia J. Neuroprotective Role of E3 Ubiquitin Ligase TRIM2 in Parkinson's Disease: Attenuation of Oxidative Stress and Apoptosis via Promoting ELAVL1 Ubiquitination. CNS Neuroscience & Therapeutics. 2026;32(8). doi:10.1002/cns.71075

BibTeX
@article{Liang2026,
  author = {Liang, Wei and Sun, WenJie and Zhao, ZhiJun and Song, Ke and Jia, JinYing},
  title = {Neuroprotective Role of E3 Ubiquitin Ligase TRIM2 in Parkinson's Disease: Attenuation of Oxidative Stress and Apoptosis via Promoting ELAVL1 Ubiquitination},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2026},
  volume = {32},
  number = {8},
  doi = {10.1002/cns.71075}
}
Kostenlos starten →